COMPANY OVERVIEW

Elusys Therapeutics is a private company focused on the development of antibody therapeutics for the treatment of infectious disease.

---

LOCATION

Pine Brook, NJ, USA

---

THERAPEUTIC AREAS

Infectious Disease

---

WEBSITE

https://www.elusys.com/#/home

---

CAREER WEBSITE

None

---

SOCIAL MEDIA

---

INVESTORS

---

---

PRESS RELEASES

Apr 27, 2022

Heat Biologics (NightHawk Biosciences) Announces that its Elusys Therapeutics Subsidiary has Executed a Contract to Deliver ANTHIM to the Canadian Government

Apr 20, 2022

Heat Biologics (“NightHawk Biosciences”) Completes Acquisition of Elusys Therapeutics

Jan 31, 2022

Elusys Therapeutics Finalizes HHS Contract to Deliver ANTHIM, Its Treatment for Inhalation Anthrax, to the U.S. Department of Health and Human Services

Oct 8, 2020

Elusys Therapeutics Receives Positive CHMP Opinion For Obiltoxaximab SFL For The Treatment Of Inhalation Anthrax USA - English Deutschland - Deutsch España - español France - Français

Dec 14, 2018

The Global Market for Anthrax Treatment (2019-2023) - Bayer, Elusys Therapeutics and Emergent BioSolutions are the Leading Players

For More Press Releases

---